Clinical trials are scientific research studies designed to find better ways to treat or prevent diseases. Rutgers Biomedical and Health Sciences (RBHS) has clinical research at every school and campus, involving hundreds of researchers. The faculty at our two medical schools, dental school, nursing schools, and other allied health schools are dedicated to moving forward discovery in drugs, biologics, devices, preventive and therapeutic strategies, behavioral research, and other interventions to improve human life. RBHS supports more than 350 clinical trials a year.
The Rutgers Clinical Research Organization is the gateway to RBHS’s statewide clinical trial activities. Dedicated to effective collaboration between industry and academia to advance care and the boundaries of health care treatment, we partner with patients, industry, and practitioners to identify appropriate investigators and academic resources to meet patients’ needs.
- Information for Participants/Interested Volunteers
- Information for Industry Collaborators
- Information for Researchers/Investigators
- Resources for Rutgers Investigators
Find Clinical Trials
Clinical trials are research studies that require the participation of patients. Search our clinical trials database to find studies that can expand treatment options by providing access to the most promising therapies and advanced technologies. Search now.
Clinical Trials In Depth
Explore school, center, and institute websites to learn more about their clinical trial activities.
Clinical Trials for Cancer
As New Jersey’s only National Cancer Institute (NCI)-designated comprehensive cancer center, the Cancer Institute of New Jersey is able to provide access to clinical trials not available at other hospitals, clinics, or doctor’s offices. The institute enrolls more than 3,000 patients in clinical trials — approximately 15 percent of all its new adult cancer patients. Nationwide fewer than 5 percent of adult cancer patients participate in clinical trials. Among the institute’s pediatric cancer patients, 70 percent are in clinical trials.
As one of only 14 National Cancer Institute-designated Minority-Based Community Clinical Oncology Programs, the New Jersey Medical School-University Hospital Cancer Center is uniquely positioned to offer state-of-the-art clinical trials to patients through numerous active protocols in dozens of NCI-approved clinical trials.